fluoxetine has been researched along with bilirubin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Benson, MA; Cai, Q; Devadas, G; Kirchner, JP; Olson, JL; Swanson, HJ; Talbot, TJ | 1 |
Chen, M; Jiang, T; Wang, H; Wang, M; Wu, F; Xu, S; Yang, H; Yin, W; Yu, W; Zhang, Y | 1 |
4 other study(ies) available for fluoxetine and bilirubin
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Acute hepatitis due to fluoxetine therapy.
Topics: Acute Disease; Adult; Alanine Transaminase; Antidepressive Agents, Second-Generation; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors | 1999 |
Inhibition of the norepinephrine transporter rescues vascular hyporeactivity to catecholamine in obstructive jaundice.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Bile Ducts; Bilirubin; Blood Pressure; Blood Vessels; Catecholamines; Fluoxetine; Ganglia, Sympathetic; Jaundice, Obstructive; Ligation; Male; Norepinephrine Plasma Membrane Transport Proteins; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley | 2021 |